+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 89Years
All Genders
ID07430085

Pain Relief Outcomes After Bupivacaine-Meloxicam Extended-Release Injection in Robot Assisted Total Knee Arthroplasty Compared to Standard Periarticular Injections

Led by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Updated on 2026-10-28

150

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research evaluates pain relief and opioid use after Robot Assisted Total Knee Arthroplasty RATKA by comparing a newer extended-release injection called Zynrelef to standard periarticular injections. The study aims to see if Zynrelef reduces pain and opioid consumption better than traditional treatments. It also looks at patients use of other over-the-counter pain medications after surgery. Participants receive one of two periarticular injections during their RATKA surgery either the extended-release bupivacaine-meloxicam Zynrelef or the standard combination of bupivacaine, ketorolac, and lidocaine. This randomized, double-blind study follows patients receiving standard care at Allegheny Health Network facilities. Data collection involves patient surveys and medical record reviews. Participants report their pain levels using the Numeric Rating Scale daily for three days after surgery and record opioid and other pain medication use during this period. Paper surveys are collected at the next postoperative visit, and researchers review electronic medical records for demographics and outcomes. The primary measures focus on opioid use and pain scores within the first three days post-operation, with safety monitored during this time as well.

CONDITIONS

Brief Title

Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA

Research Team

O

Obinna Ajah, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here